Manuscripts are being solicited for inclusion in a special issue of General Hospital Psychiatry entitled, “Medical Issues in Psychiatric Oncology,” edited by William Pirl, MD (Harvard Medical School/Dana Farber Cancer Center) and Scott Irwin, MD, PhD (UCSD/ Cedars-Sinai).
Welcomed are conceptual or empirical manuscripts, including review articles, original research reports, and brief communications, in keeping with the usual article formats for General Hospital Psychiatry.
This special issue will focus on the following topics: 1) neuropsychiatric side effects of cancer treatments, including immunotherapies and targeted treatments; 2) psychiatric medication use in oncology (rapid titration of medications, off-label uses, and drug-drug interactions); 3) relationships of genes, inflammation, and other host factors with psychiatric symptoms in oncology patients; and 4) special considerations in diagnosing psychiatric disorders in oncology.
As new advances transform the treatment of cancer, new psychiatric complications and challenges continue to arise. The goal of this issue is to assemble timely evidence and observations which may help to guide psychiatric care and further research.
Authors are invited to submit a full manuscript, due December 15, 2018. All manuscripts will be subject to full editorial board and peer review. We anticipate that the special issue will be published in Summer 2019.
Approximate Timeline for Submissions:
For more information, see the GHP guide for authors: https://www.elsevier.com/journals/general-hospital-psychiatry/0163-8343/guide-for-authors
Papers can be submitted at the main GHP site: https://www.journals.elsevier.com/general-hospital-psychiatry